Share on LinkedInShare on LinkedIn

ARTICLE · 26 MARCH 2019

GDPR And Clinical Trials—More Clarity?

Arnold & Porter
Arnold & Porter
Contributor
Arnold & Porter

Arnold & Porter

With over 1,000 lawyers across 16 offices worldwide, Arnold & Porter is renowned for its...

View firm profile
Explore more from Arnold & Porter

On 23 January 2019, the European Data Protection Board (EDPB) adopted an Opinion on the interplay between the Clinical Trials Regulation (CTR) ...

European UnionPrivacy

On 23 January 2019, the European Data Protection Board (EDPB) adopted an Opinion on the interplay between the Clinical Trials Regulation (CTR), which is likely to become applicable in 2020 (if not later), and the European General Data Protection Regulation (GDPR). The Opinion focusses on an area provoking much discussion since the GDPR came into force; that is, as we discussed in our previous blog, which legal bases under the GDPR are appropriate for processing personal data in the context of clinical trials?

The Consent Overlap

While focussing on the CTR, the principles in the Opinion would apply equally to the Clinical Trials Directive. In all cases, the sponsor must obtain the explicit, unambiguous and freely given consent of subjects before commencing the trial. This consent requirement is distinct from any consent provided under the GDPR as a legal basis for processing personal data.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from